» Articles » PMID: 25503289

Subgenotypes and Mutations in the S and Polymerase Genes of Hepatitis B Virus Carriers in the West Bank, Palestine

Overview
Journal PLoS One
Date 2014 Dec 16
PMID 25503289
Citations 14
Authors
Affiliations
Soon will be listed here.
Abstract

The mutation rate and genetic variability of hepatitis B virus (HBV) are crucial factors for efficient treatment and successful vaccination against HBV. Until today, genetic properties of this virus among the Palestinian population remain unknown. Therefore, we performed genetic analysis of the overlapping S and polymerase genes of HBV, isolated from 40 Palestinian patients' sera. All patients were HBsAg positive and presented with a viral load above 105 HBV genome copies/ml. The genotyping results of the S gene demonstrated that HBV D1 was detected in 90% of the samples representing the most prominent subgenotype among Palestinians carrying HBV. Various mutations existed within the S gene; in five patients four known escape mutations including the common G145R and D144E were found. Furthermore, a ratio of 4.25 of non-synonymous to synonymous mutations in the S gene indicated a strong selection pressure on the HBs antigen loops of HBV strains circulating in those Palestinian patients. Although all patients were treatment-naïve, with the exception of one, several mutations were found in the HBV polymerase gene, but none pointed to drug resistance. The study presented here is the first report to address subgenotypes and mutation analyses of HBV S and polymerase genes in Palestine.

Citing Articles

Full-Length Genome Sequencing and Analysis of Hepatitis B Viruses Isolated from Iraqi Patients.

Mamoori Y, Ahmed I, Mahmood A, Al-Waysi S Int J Microbiol. 2024; 2024:6826495.

PMID: 38716461 PMC: 11074772. DOI: 10.1155/2024/6826495.


Mutations in the S gene of hepatitis B virus in three generations of patients with chronic hepatitis B.

Naderi M, Hosseini S, Behnampour N, Shahramian I, Moradi A Virus Genes. 2023; 59(5):662-669.

PMID: 37308753 DOI: 10.1007/s11262-023-02012-z.


A Novel Insertion in the Hepatitis B Virus Surface Protein Leading to Hyperglycosylation Causes Diagnostic and Immune Escape.

Lehmann F, Slanina H, Roderfeld M, Roeb E, Trebicka J, Ziebuhr J Viruses. 2023; 15(4).

PMID: 37112819 PMC: 10144012. DOI: 10.3390/v15040838.


Variable Proportions of Phylogenetic Clustering and Low Levels of Antiviral Drug Resistance among the Major HBV Sub-Genotypes in the Middle East and North Africa.

Athamneh R, Arikan A, Sayan M, Mahafzah A, Sallam M Pathogens. 2021; 10(10).

PMID: 34684283 PMC: 8540944. DOI: 10.3390/pathogens10101333.


Detection of S-HBsAg Mutations in Patients with Hematologic Malignancies.

Konopleva M, Belenikin M, Shanko A, Bazhenov A, Kiryanov S, Tupoleva T Diagnostics (Basel). 2021; 11(6).

PMID: 34072185 PMC: 8228241. DOI: 10.3390/diagnostics11060969.


References
1.
Ghany M, Liang T . Drug targets and molecular mechanisms of drug resistance in chronic hepatitis B. Gastroenterology. 2007; 132(4):1574-85. DOI: 10.1053/j.gastro.2007.02.039. View

2.
Jursch C, Gerlich W, Glebe D, Schaefer S, Marie O, Thraenhart O . Molecular approaches to validate disinfectants against human hepatitis B virus. Med Microbiol Immunol. 2002; 190(4):189-97. DOI: 10.1007/s00430-001-0103-0. View

3.
Kim J, Jung Y, Joo M, Kim J, Yim H, Park J . Hepatitis B viral surface mutations in patients with adefovir resistant chronic hepatitis B with A181T/V polymerase mutations. J Korean Med Sci. 2010; 25(2):257-64. PMC: 2811294. DOI: 10.3346/jkms.2010.25.2.257. View

4.
Araujo N, Vianna C, Moraes M, Gomes S . Expression of Hepatitis B virus surface antigen (HBsAg) from genotypes A, D and F and influence of amino acid variations related or not to genotypes on HBsAg detection. Braz J Infect Dis. 2010; 13(4):266-71. DOI: 10.1590/s1413-86702009000400005. View

5.
Hanada K, Shiu S, Li W . The nonsynonymous/synonymous substitution rate ratio versus the radical/conservative replacement rate ratio in the evolution of mammalian genes. Mol Biol Evol. 2007; 24(10):2235-41. DOI: 10.1093/molbev/msm152. View